Related Experiment Videos

Thalamic tumors in children. Long-term follow-up and treatment guidelines

Journal of Neurosurgery
|October 1, 1984
PubMed

Insights

This study on pediatric thalamic tumors found that malignant types were fatal, while benign tumors had a better prognosis. Open biopsy and radiation are recommended for thalamic tumors in children.

Area of Science:

  • Pediatric Oncology
  • Neurosurgery
  • Neuroradiology

Background:

  • Thalamic tumors are rare and challenging pediatric neoplasms.
  • Diagnosis and treatment have evolved with advancements like computed tomography (CT).
  • Understanding outcomes is crucial for guiding therapeutic strategies.

Purpose of the Study:

  • To review the clinical course and outcomes of children with thalamic tumors.
  • To evaluate the impact of diagnostic era (pre-CT vs. CT) on patient management.
  • To provide evidence-based recommendations for the surgical and oncological management of pediatric thalamic tumors.

Main Methods:

  • Retrospective review of 60 pediatric patients with thalamic tumors treated between 1951 and 1983.
  • Analysis of diagnostic methods (neuroradiology, histology), surgical interventions (biopsy, resection), and adjuvant therapies (radiation, shunting).
  • Comparison of outcomes based on tumor histology (benign vs. malignant) and diagnostic era.

Main Results:

  • Malignant thalamic tumors had a uniformly fatal outcome (20 patients died, mean survival 1.1 years).
  • Benign thalamic tumors showed variable outcomes, with 11 of 19 patients dying (mean survival 5.3 years) and 8 surviving (mean follow-up 7.2 years).
  • Cerebrospinal fluid shunting was required in 36 patients; open biopsy was performed in 20, and partial resection in 21.

Conclusions:

  • Open biopsy for suspected thalamic tumors is recommended, followed by resection if feasible and safe.
  • Radiation therapy should be considered for select cases, particularly those with malignant histology.
  • Early diagnosis and appropriate surgical intervention are critical for improving outcomes in pediatric thalamic tumors.

Related Concept Videos